Medical, Drugs | featured news

A comprehensive study of the genetics of a common lung cancer finds that more than half the tumors have mutations that might be treated by drugs that are already in the pipeline or that could be developed.

The new class of drug, which can be taken orally, is designed to protect the brain by combating the damaging effects of inflammation. Results from early stage clinical trials have yet to be announced, but studies on animals suggest the therapy could be effective against a wide range of conditions which also include motor neurone disease and complications from traumatic brain injury.

Medical science efforts to harness the power of the immune system against cancer are beginning to bear fruit after decades of frustration, opening up a hopeful new front in the long battle against the disease.

The tantalising prospect of treating a range of brain diseases, such as Alzheimer's and Parkinson's, all with the same drug has been raised by UK researchers.

Without warning, adventure junkie Mike Scholes lost most of his sight. But after participating in a clinical trial, he has regained much of the vision he lost due to a rare condition.

Presidential hopeful Michele Bachmann isn't alone when it comes to suffering from migraines.

The drugs, mainly for men with late-stage prostate cancer, can extend lives for additional months, but some cost more than $90,000 for a course of treatment.

A new drug combination can help patients with pancreatic cancer live months longer than on standard therapy.

The drug, a synthetic form of the hormone progesterone, is being marketed under the name Makena.

Dr. Neena Abraham discusses the hazards of taking a baby aspirin a day.